Osteopontin as a Biomarker in Pancreatitis
PtitStudien
Osteopontin and Other Potential Biomarkers and Factors Important for Prognosis in Pancreatitis
1 other identifier
observational
103
1 country
1
Brief Summary
In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedFirst Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedMay 31, 2023
May 1, 2023
5.6 years
May 11, 2023
May 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Se-osteopontin
Se-osteopontin will be measured at admission and on day 2 and 3 of hospital stay. The change over time will be correlated to severety of pancreatitis as classified in the current Atlanta classification.
Within 3 days from diagnosis
Study Arms (1)
Pancreatits
Patients with pancreatitis based ont the Atlanta criteria
Interventions
Eligibility Criteria
Patients with diagnosis of pancreatitis
You may qualify if:
- Diagnosis of pancreatitis
You may not qualify if:
- Pregnancy, lactation, unable to understand the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linkoping University Hospital
Linköping, 582 72, Sweden
Biospecimen
Serum
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 11, 2023
First Posted
May 31, 2023
Study Start
March 3, 2011
Primary Completion
October 19, 2016
Study Completion
January 31, 2023
Last Updated
May 31, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share